{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T07:56:04Z","timestamp":1790582164410,"version":"4.1.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Italian Ministry of Research and University","award":["PRIN 2022 project number: 20229XWM5L"],"award-info":[{"award-number":["PRIN 2022 project number: 20229XWM5L"]}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["Progetto Eccellenza (2023\u20132027)"],"award-info":[{"award-number":["Progetto Eccellenza (2023\u20132027)"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PNRR 2022 project number: 20229XWM5L"],"award-info":[{"award-number":["PNRR 2022 project number: 20229XWM5L"]}],"id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["Ricerca corrente 08C211"],"award-info":[{"award-number":["Ricerca corrente 08C211"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurodevelop Disord"],"DOI":"10.1186\/s11689-026-09728-7","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T11:53:46Z","timestamp":1787918026000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Phenotyping iPSC-derived neurons from Angelman patients and partial rescue via JNK pathway inactivation"],"prefix":"10.1186","volume":"18","author":[{"given":"Valentina","family":"Alari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Cambria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"De Cesari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Vimercati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milena","family":"Crippa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Perego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Larizza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Tonazzini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia","family":"Antonucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,28]]},"reference":[{"key":"9728_CR1","unstructured":"Dagli AI, Mathews J, Williams CA. Angelman Syndrome. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, eds. GeneReviews\u00ae. University of Washington, Seattle; 1993. Accessed August 13, 2025. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1144\/"},{"issue":"5","key":"9728_CR2","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/ajmg.a.31074","volume":"140","author":"CA Williams","year":"2005","unstructured":"Williams CA, Beaudet AL, Clayton-Smith J, et al. Angelman syndrome 2005: updated consensus for diagnostic criteria. Am J Med Genet A. 2005;140(5):413\u20138. https:\/\/doi.org\/10.1002\/ajmg.a.31074.","journal-title":"Am J Med Genet A"},{"issue":"4","key":"9728_CR3","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3390\/genes11040355","volume":"11","author":"F Cerrato","year":"2020","unstructured":"Cerrato F, Sparago A, Ariani F, et al. DNA methylation in the diagnosis of monogenic diseases. Genes (Basel). 2020;11(4):355. https:\/\/doi.org\/10.3390\/genes11040355.","journal-title":"Genes (Basel)"},{"key":"9728_CR4","doi-asserted-by":"publisher","first-page":"102899","DOI":"10.1016\/j.conb.2024.102899","volume":"88","author":"JC Krzeski","year":"2024","unstructured":"Krzeski JC, Judson MC, Philpot BD. Neuronal UBE3A substrates hold therapeutic potential for Angelman syndrome. Curr Opin Neurobiol. 2024;88:102899. https:\/\/doi.org\/10.1016\/j.conb.2024.102899.","journal-title":"Curr Opin Neurobiol"},{"issue":"6","key":"9728_CR5","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1073\/pnas.1815279116","volume":"116","author":"JS Hsiao","year":"2019","unstructured":"Hsiao JS, Germain ND, Wilderman A, et al. A bipartite boundary element restricts UBE3A imprinting to mature neurons. Proc Natl Acad Sci U S A. 2019;116(6):2181\u20136. https:\/\/doi.org\/10.1073\/pnas.1815279116.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"9728_CR6","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1002\/cne.23507","volume":"522","author":"MC Judson","year":"2014","unstructured":"Judson MC, Sosa-Pagan JO, Del Cid WA, Han JE, Philpot BD. Allelic specificity of Ube3a expression in the mouse brain during postnatal development. J Comp Neurol. 2014;522(8):1874\u201396. https:\/\/doi.org\/10.1002\/cne.23507.","journal-title":"J Comp Neurol"},{"key":"9728_CR7","doi-asserted-by":"publisher","first-page":"30792","DOI":"10.1038\/srep30792","volume":"6","author":"J Stanurova","year":"2016","unstructured":"Stanurova J, Neureiter A, Hiber M, et al. Angelman syndrome-derived neurons display late onset of paternal UBE3A silencing. Sci Rep. 2016;6:30792. https:\/\/doi.org\/10.1038\/srep30792.","journal-title":"Sci Rep"},{"issue":"4","key":"9728_CR8","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.3390\/ijms22041660","volume":"22","author":"I Baldwin","year":"2021","unstructured":"Baldwin I, Shafer RL, Hossain WA, et al. Genomic, clinical, and behavioral characterization of 15q11.2 BP1-BP2 deletion (Burnside-Butler) syndrome in five families. Int J Mol Sci. 2021;22(4):1660. https:\/\/doi.org\/10.3390\/ijms22041660.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"9728_CR9","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.1038\/s41380-020-0858-6","volume":"26","author":"M Keute","year":"2021","unstructured":"Keute M, Miller MT, Krishnan ML, et al. Angelman syndrome genotypes manifest varying degrees of clinical severity and developmental impairment. Mol Psychiatry. 2021;26(7):3625\u201333. https:\/\/doi.org\/10.1038\/s41380-020-0858-6.","journal-title":"Mol Psychiatry"},{"issue":"4","key":"9728_CR10","doi-asserted-by":"publisher","first-page":"100342","DOI":"10.1016\/j.xhgg.2024.100342","volume":"5","author":"M Fujimoto","year":"2024","unstructured":"Fujimoto M, Nakamura Y, Hosoki K, et al. Genotype-phenotype correlation over time in Angelman syndrome: researching 134 patients. Hum Genet Genomics Adv. 2024;5(4):100342. https:\/\/doi.org\/10.1016\/j.xhgg.2024.100342.","journal-title":"Hum Genet Genomics Adv"},{"key":"9728_CR11","doi-asserted-by":"publisher","first-page":"101363","DOI":"10.1016\/j.scr.2018.101363","volume":"34","author":"T Niki","year":"2019","unstructured":"Niki T, Imamura K, Enami T, Kinoshita M, Inoue H. Establishment of human induced pluripotent stem cell line from a patient with Angelman syndrome carrying the deletion of maternal chromosome 15q.112\u2013q13. Stem Cell Res. 2019;34:101363. https:\/\/doi.org\/10.1016\/j.scr.2018.101363.","journal-title":"Stem Cell Res."},{"issue":"41","key":"9728_CR12","doi-asserted-by":"publisher","first-page":"17668","DOI":"10.1073\/pnas.1004487107","volume":"107","author":"SJ Chamberlain","year":"2010","unstructured":"Chamberlain SJ, Chen PF, Ng KY, et al. Induced pluripotent stem cell models of the genomic imprinting disorders Angelman and Prader-Willi syndromes. Proc Natl Acad Sci U S A. 2010;107(41):17668\u201373. https:\/\/doi.org\/10.1073\/pnas.1004487107.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"23","key":"9728_CR13","doi-asserted-by":"publisher","first-page":"3999","DOI":"10.1093\/hmg\/ddy274","volume":"27","author":"D P\u00f3lvora-Brand\u00e3o","year":"2018","unstructured":"P\u00f3lvora-Brand\u00e3o D, Joaquim M, Godinho I, et al. Loss of hierarchical imprinting regulation at the Prader-Willi\/Angelman syndrome locus in human iPSCs. Hum Mol Genet. 2018;27(23):3999\u20134011. https:\/\/doi.org\/10.1093\/hmg\/ddy274.","journal-title":"Hum Mol Genet"},{"issue":"8","key":"9728_CR14","doi-asserted-by":"publisher","first-page":"100360","DOI":"10.1016\/j.xcrm.2021.100360","volume":"2","author":"NJ Pandya","year":"2021","unstructured":"Pandya NJ, Wang C, Costa V, et al. Secreted retrovirus-like GAG-domain-containing protein PEG10 is regulated by UBE3A and is involved in Angelman syndrome pathophysiology. Cell Rep Med. 2021;2(8):100360. https:\/\/doi.org\/10.1016\/j.xcrm.2021.100360.","journal-title":"Cell Rep Med"},{"key":"9728_CR15","doi-asserted-by":"publisher","first-page":"102757","DOI":"10.1016\/j.scr.2022.102757","volume":"61","author":"C Maranga","year":"2022","unstructured":"Maranga C, Pereira C, Raposo AC, et al. Generation and characterization of induced pluripotent stem cell line (IBBISTi004-A) from an Angelman syndrome patient carrying a class II deletion of the maternal chromosome 15q11.2\u2013q13. Stem Cell Res. 2022;61:102757. https:\/\/doi.org\/10.1016\/j.scr.2022.102757.","journal-title":"Stem Cell Res."},{"key":"9728_CR16","doi-asserted-by":"publisher","unstructured":"Cam\u00f5es Dos Santos J, Cazaux Mateus F, Arez M, Bekman EP, da Rocha ST. Generation of two pairs of induced pluripotent stem cells from Angelman syndrome patients with class I 15q11.2-q13.1 deletions and their unaffected familial controls. Stem Cell Res. 2025;86:103741. https:\/\/doi.org\/10.1016\/j.scr.2025.103741","DOI":"10.1016\/j.scr.2025.103741"},{"issue":"2","key":"9728_CR17","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1159\/000430916","volume":"1","author":"DK Das","year":"2015","unstructured":"Das DK, Tapias V, D\u2019Aiuto L, et al. Genetic and morphological features of human iPSC-derived neurons with chromosome 15q11.2 (BP1-BP2) deletions. Mol Neuropsychiatry. 2015;1(2):116\u201323. https:\/\/doi.org\/10.1159\/000430916.","journal-title":"Mol Neuropsychiatry."},{"issue":"4","key":"9728_CR18","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663\u201376. https:\/\/doi.org\/10.1016\/j.cell.2006.07.024.","journal-title":"Cell"},{"issue":"6","key":"9728_CR19","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s13577-025-01287-8","volume":"38","author":"F Cazaux Mateus","year":"2025","unstructured":"Cazaux Mateus F, Cam\u00f5es Dos Santos J, Arez M, Bekman EP, da Rocha ST. A stem cell-based toolkit to model Angelman syndrome caused by paternal uniparental disomy of chromosome 15. Hum Cell. 2025;38(6):161. https:\/\/doi.org\/10.1007\/s13577-025-01287-8.","journal-title":"Hum Cell"},{"key":"9728_CR20","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.scr.2018.09.015","volume":"33","author":"A Neureiter","year":"2018","unstructured":"Neureiter A, Br\u00e4ndl B, Hiber M, Tandon R, M\u00fcller FJ, Steenpass L. Generation of an iPSC line of a patient with Angelman syndrome due to an imprinting defect. Stem Cell Res. 2018;33:20\u20134. https:\/\/doi.org\/10.1016\/j.scr.2018.09.015.","journal-title":"Stem Cell Res"},{"key":"9728_CR21","doi-asserted-by":"publisher","first-page":"15038","DOI":"10.1038\/ncomms15038","volume":"8","author":"JJ Fink","year":"2017","unstructured":"Fink JJ, Robinson TM, Germain ND, et al. Disrupted neuronal maturation in Angelman syndrome-derived induced pluripotent stem cells. Nat Commun. 2017;8:15038. https:\/\/doi.org\/10.1038\/ncomms15038.","journal-title":"Nat Commun"},{"key":"9728_CR22","doi-asserted-by":"publisher","first-page":"102791","DOI":"10.1016\/j.scr.2022.102791","volume":"62","author":"S Li","year":"2022","unstructured":"Li S, Zhu Q, Cai Y, Yang Q. Generation of an induced pluripotent stem cell line from a patient with Angelman syndrome carrying UBE3A mutation. Stem Cell Res. 2022;62:102791. https:\/\/doi.org\/10.1016\/j.scr.2022.102791.","journal-title":"Stem Cell Res"},{"issue":"11","key":"9728_CR23","doi-asserted-by":"publisher","first-page":"e0311565","DOI":"10.1371\/journal.pone.0311565","volume":"19","author":"RB Gilmore","year":"2024","unstructured":"Gilmore RB, Gorka D, Stoddard CE, Sonawane P, Cotney J, Chamberlain SJ. Generation of isogenic models of Angelman syndrome and Prader-Willi syndrome in CRISPR\/Cas9-engineered human embryonic stem cells. PLoS ONE. 2024;19(11):e0311565. https:\/\/doi.org\/10.1371\/journal.pone.0311565.","journal-title":"PLoS ONE"},{"issue":"1","key":"9728_CR24","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/hmg\/ddm288","volume":"17","author":"SV Dindot","year":"2008","unstructured":"Dindot SV, Antalffy BA, Bhattacharjee MB, Beaudet AL. The Angelman syndrome ubiquitin ligase localizes to the synapse and nucleus, and maternal deficiency results in abnormal dendritic spine morphology. Hum Mol Genet. 2008;17(1):111\u20138. https:\/\/doi.org\/10.1093\/hmg\/ddm288.","journal-title":"Hum Mol Genet"},{"issue":"6663","key":"9728_CR25","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1126\/science.ade8978","volume":"381","author":"K Furusawa","year":"2023","unstructured":"Furusawa K, Ishii K, Tsuji M, Tokumitsu N, Hasegawa E, Emoto K. Presynaptic Ube3a E3 ligase promotes synapse elimination through down-regulation of BMP signaling. Science. 2023;381(6663):1197\u2013205. https:\/\/doi.org\/10.1126\/science.ade8978.","journal-title":"Science"},{"issue":"6","key":"9728_CR26","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1038\/s41380-023-02038-7","volume":"28","author":"L Simchi","year":"2023","unstructured":"Simchi L, Gupta PK, Feuermann Y, Kaphzan H. Elevated ROS levels during the early development of Angelman syndrome alter the apoptotic capacity of the developing neural precursor cells. Mol Psychiatry. 2023;28(6):2382\u201397. https:\/\/doi.org\/10.1038\/s41380-023-02038-7.","journal-title":"Mol Psychiatry"},{"issue":"1","key":"9728_CR27","doi-asserted-by":"publisher","first-page":"31 10.1186\/s132","DOI":"10.1186\/s13229-024-00608-2","volume":"15","author":"PK Gupta","year":"2024","unstructured":"Gupta PK, Barak S, Feuermann Y, Goobes G, Kaphzan H. 1H-NMR-based metabolomics reveals metabolic alterations in early development of a mouse model of Angelman syndrome. Mol Autism. 2024;15(1):31 10.1186\/s13229-024-00608\u20132.","journal-title":"Mol Autism"},{"issue":"2","key":"9728_CR28","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1046\/j.1471-4159.2001.00400.x","volume":"78","author":"SR Bruckner","year":"2001","unstructured":"Bruckner SR, Tammariello SP, Kuan CY, Flavell RA, Rakic P, Estus S. JNK3 contributes to c-Jun activation and apoptosis but not oxidative stress in nerve growth factor-deprived sympathetic neurons. J Neurochem. 2001;78(2):298\u2013303. https:\/\/doi.org\/10.1046\/j.1471-4159.2001.00400.x.","journal-title":"J Neurochem"},{"issue":"8","key":"9728_CR29","doi-asserted-by":"publisher","first-page":"4113","DOI":"10.3390\/ijms23084113","volume":"23","author":"CA Musi","year":"2022","unstructured":"Musi CA, Marchini G, Giani A, et al. Colocalization and Interaction Study of Neuronal JNK3, JIP1, and \u03b2-Arrestin2 Together with PSD95. Int J Mol Sci. 2022;23(8):4113. https:\/\/doi.org\/10.3390\/ijms23084113.","journal-title":"Int J Mol Sci"},{"key":"9728_CR30","doi-asserted-by":"publisher","first-page":"104812","DOI":"10.1016\/j.nbd.2020.104812","volume":"140","author":"CA Musi","year":"2020","unstructured":"Musi CA, Agr\u00f2 G, Buccarello L, Camuso S, Borsello T. JNK signaling activation in the Ube3a maternal deficient mouse model: its specific inhibition prevents post-synaptic protein-enriched fraction alterations and cognitive deficits in Angelman syndrome model. Neurobiol Dis. 2020;140:104812. https:\/\/doi.org\/10.1016\/j.nbd.2020.104812.","journal-title":"Neurobiol Dis"},{"issue":"1","key":"9728_CR31","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2337\/diabetes.50.1.77","volume":"50","author":"C Bonny","year":"2001","unstructured":"Bonny C, Oberson A, Negri S, Sauser C, Schorderet DF. Cell-permeable peptide inhibitors of JNK: novel blockers of beta-cell death. Diabetes. 2001;50(1):77\u201382. https:\/\/doi.org\/10.2337\/diabetes.50.1.77.","journal-title":"Diabetes"},{"issue":"1","key":"9728_CR32","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.vascn.2014.04.001","volume":"70","author":"E Davoli","year":"2014","unstructured":"Davoli E, Sclip A, Cecchi M, et al. Determination of tissue levels of a neuroprotectant drug: the cell permeable JNK inhibitor peptide. J Pharmacol Toxicol Methods. 2014;70(1):55\u201361. https:\/\/doi.org\/10.1016\/j.vascn.2014.04.001.","journal-title":"J Pharmacol Toxicol Methods"},{"issue":"1","key":"9728_CR33","doi-asserted-by":"publisher","first-page":"14296","DOI":"10.1038\/s41598-018-32592-y","volume":"8","author":"K Stefanoska","year":"2018","unstructured":"Stefanoska K, Bertz J, Volkerling AM, van der Hoven J, Ittner LM, Ittner A. Neuronal MAP kinase p38\u03b1 inhibits c-Jun N-terminal kinase to modulate anxiety-related behaviour. Sci Rep. 2018;8(1):14296. https:\/\/doi.org\/10.1038\/s41598-018-32592-y.","journal-title":"Sci Rep"},{"issue":"1","key":"9728_CR34","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.neuroscience.2008.11.049","volume":"159","author":"M Repici","year":"2009","unstructured":"Repici M, Mare L, Colombo A, et al. C-Jun N-terminal kinase binding domain-dependent phosphorylation of mitogen-activated protein kinase kinase 4 and mitogen-activated protein kinase kinase 7 and balancing cross-talk between c-Jun N-terminal kinase and extracellular signal-regulated kinase pathways in cortical neurons. Neuroscience. 2009;159(1):94\u2013103. https:\/\/doi.org\/10.1016\/j.neuroscience.2008.11.049.","journal-title":"Neuroscience"},{"issue":"3","key":"9728_CR35","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.mcn.2011.12.005","volume":"49","author":"Y Zhao","year":"2012","unstructured":"Zhao Y, Spigolon G, Bonny C, Culman J, Vercelli A, Herdegen T. The JNK inhibitor D-JNKI-1 blocks apoptotic JNK signaling in brain mitochondria. Mol Cell Neurosci. 2012;49(3):300\u201310. https:\/\/doi.org\/10.1016\/j.mcn.2011.12.005.","journal-title":"Mol Cell Neurosci"},{"issue":"7","key":"9728_CR36","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1161\/01.STR.0000131480.03994.b1","volume":"35","author":"L Hirt","year":"2004","unstructured":"Hirt L, Badaut J, Thevenet J, et al. D-JNKI1, a cell-penetrating c-Jun-N-terminal kinase inhibitor, protects against cell death in severe cerebral ischemia. Stroke. 2004;35(7):1738\u201343. https:\/\/doi.org\/10.1161\/01.STR.0000131480.03994.b1.","journal-title":"Stroke"},{"key":"9728_CR37","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.heares.2018.03.003","volume":"368","author":"AA Eshraghi","year":"2018","unstructured":"Eshraghi AA, Aranke M, Salvi R, et al. Preclinical and clinical otoprotective applications of cell-penetrating peptide D-JNKI-1 (AM-111). Hear Res. 2018;368:86\u201391. https:\/\/doi.org\/10.1016\/j.heares.2018.03.003.","journal-title":"Hear Res"},{"issue":"1","key":"9728_CR38","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1186\/s12915-021-01190-2","volume":"19","author":"CA Musi","year":"2021","unstructured":"Musi CA, Castaldo AM, Valsecchi AE, et al. JNK signaling provides a novel therapeutic target for Rett syndrome. BMC Biol. 2021;19(1):256. https:\/\/doi.org\/10.1186\/s12915-021-01190-2.","journal-title":"BMC Biol"},{"key":"9728_CR39","doi-asserted-by":"publisher","unstructured":"Alari V, Russo S, Rovina D, et al. Generation of three iPSC lines (IAIi002, IAIi004, IAIi003) from Rubinstein-Taybi syndrome 1 patients carrying CREBBP non sense c.4435G>T, p.(Gly1479*) and c.3474G>A, p.(Trp1158*) and missense c.4627G>T, p.(Asp1543Tyr) mutations. Stem Cell Research. 2019;40:101553. https:\/\/doi.org\/10.1016\/j.scr.2019.101553","DOI":"10.1016\/j.scr.2019.101553"},{"issue":"11","key":"9728_CR40","doi-asserted-by":"publisher","first-page":"5777","DOI":"10.3390\/ijms22115777","volume":"22","author":"V Alari","year":"2021","unstructured":"Alari V, Scalmani P, Ajmone PF, et al. Histone deacetylase inhibitors ameliorate morphological defects and hypoexcitability of iPSC-neurons from Rubinstein-Taybi patients. Int J Mol Sci. 2021;22(11):5777. https:\/\/doi.org\/10.3390\/ijms22115777.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"9728_CR41","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1002\/adhm.201500268","volume":"4","author":"I Tonazzini","year":"2015","unstructured":"Tonazzini I, Jacchetti E, Meucci S, Beltram F, Cecchini M. Schwann cell contact guidance versus boundary -interaction in functional wound healing along nano and microstructured membranes. Adv Healthc Mater. 2015;4(12):1849\u201360. https:\/\/doi.org\/10.1002\/adhm.201500268.","journal-title":"Adv Healthc Mater"},{"issue":"2","key":"9728_CR42","doi-asserted-by":"publisher","first-page":"025708","DOI":"10.1088\/1361-6528\/abbb03","volume":"32","author":"R Mezzena","year":"2021","unstructured":"Mezzena R, Masciullo C, Antonini S, et al. Study of adhesion and migration dynamics in ubiquitin E3A ligase (UBE3A)-silenced SYSH5Y neuroblastoma cells by micro-structured surfaces. Nanotechnology. 2021;32(2):025708. https:\/\/doi.org\/10.1088\/1361-6528\/abbb03.","journal-title":"Nanotechnology"},{"issue":"3","key":"9728_CR43","doi-asserted-by":"publisher","first-page":"e133654","DOI":"10.1172\/jci.insight.133654","volume":"6","author":"L Pizzamiglio","year":"2021","unstructured":"Pizzamiglio L, Focchi E, Cambria C, et al. The DNA repair protein ATM as a target in autism spectrum disorder. JCI Insight. 2021;6(3):e133654. https:\/\/doi.org\/10.1172\/jci.insight.133654.","journal-title":"JCI Insight"},{"issue":"7","key":"9728_CR44","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/nrn.2016.46","volume":"17","author":"J Mertens","year":"2016","unstructured":"Mertens J, Marchetto MC, Bardy C, Gage FH. Evaluating cell reprogramming, differentiation and conversion technologies in neuroscience. Nat Rev Neurosci. 2016;17(7):424\u201337. https:\/\/doi.org\/10.1038\/nrn.2016.46.","journal-title":"Nat Rev Neurosci"},{"key":"9728_CR45","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.scr.2018.05.019","volume":"30","author":"V Alari","year":"2018","unstructured":"Alari V, Russo S, Terragni B, et al. iPSC-derived neurons of CREBBP - and EP300 -mutated Rubinstein-Taybi syndrome patients show morphological alterations and hypoexcitability. Stem Cell Res. 2018;30:130\u201340. https:\/\/doi.org\/10.1016\/j.scr.2018.05.019.","journal-title":"Stem Cell Res"},{"issue":"17","key":"9728_CR46","doi-asserted-by":"publisher","first-page":"4888","DOI":"10.1523\/JNEUROSCI.4204-15.2016","volume":"36","author":"H Kim","year":"2016","unstructured":"Kim H, Kunz PA, Mooney R, Philpot BD, Smith SL. Maternal loss of Ube3a impairs experience-driven dendritic spine maintenance in the developing visual cortex. J Neurosci. 2016;36(17):4888\u201394. https:\/\/doi.org\/10.1523\/JNEUROSCI.4204-15.2016.","journal-title":"J Neurosci"},{"issue":"8","key":"9728_CR47","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.3390\/cells9081802","volume":"9","author":"R Nakano","year":"2020","unstructured":"Nakano R, Nakayama T, Sugiya H. Biological Properties of JNK3 and Its Function in Neurons, Astrocytes, Pancreatic \u03b2-Cells and Cardiovascular Cells. Cells. 2020;9(8):1802. https:\/\/doi.org\/10.3390\/cells9081802.","journal-title":"Cells"},{"issue":"6","key":"9728_CR48","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.tins.2011.04.001","volume":"34","author":"AM Mabb","year":"2011","unstructured":"Mabb AM, Judson MC, Zylka MJ, Philpot BD. Angelman syndrome: insights into genomic imprinting and neurodevelopmental phenotypes. Trends Neurosci. 2011;34(6):293\u2013303. https:\/\/doi.org\/10.1016\/j.tins.2011.04.001.","journal-title":"Trends Neurosci"},{"issue":"48","key":"9728_CR49","doi-asserted-by":"publisher","first-page":"17637","DOI":"10.1523\/JNEUROSCI.4162-11.2011","volume":"31","author":"H Kaphzan","year":"2011","unstructured":"Kaphzan H, Buffington SA, Jung JI, Rasband MN, Klann E. Alterations in intrinsic membrane properties and the axon initial segment in a mouse model of Angelman syndrome. J Neurosci. 2011;31(48):17637\u201348. https:\/\/doi.org\/10.1523\/JNEUROSCI.4162-11.2011.","journal-title":"J Neurosci"},{"issue":"1","key":"9728_CR50","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1523\/JNEUROSCI.2509-12.2013","volume":"33","author":"S Miao","year":"2013","unstructured":"Miao S, Chen R, Ye J, et al. The Angelman syndrome protein Ube3a is required for polarized dendrite morphogenesis in pyramidal neurons. J Neurosci. 2013;33(1):327\u201333. https:\/\/doi.org\/10.1523\/JNEUROSCI.2509-12.2013.","journal-title":"J Neurosci"},{"issue":"1","key":"9728_CR51","doi-asserted-by":"publisher","first-page":"25091","DOI":"10.1038\/s41598-025-10912-3","volume":"15","author":"R Saiga","year":"2025","unstructured":"Saiga R, Shiga K, Maruta Y, et al. Structural differences between human and mouse neurons and their implementation in generative AIs. Sci Rep. 2025;15(1):25091. https:\/\/doi.org\/10.1038\/s41598-025-10912-3.","journal-title":"Sci Rep"},{"key":"9728_CR52","doi-asserted-by":"publisher","first-page":"e90017","DOI":"10.7554\/eLife.90017","volume":"12","author":"HHW Wong","year":"2023","unstructured":"Wong HHW, Chou CYC, Watt AJ, Sj\u00f6str\u00f6m PJ. Comparing mouse and human brains. Elife. 2023;12:e90017. https:\/\/doi.org\/10.7554\/eLife.90017.","journal-title":"Elife"},{"issue":"1","key":"9728_CR53","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1159\/000476034","volume":"3","author":"P Dimitrion","year":"2017","unstructured":"Dimitrion P, Zhi Y, Clayton D, et al. Low-Density Neuronal Cultures from Human Induced Pluripotent Stem Cells. Mol Neuropsychiatry. 2017;3(1):28\u201336. https:\/\/doi.org\/10.1159\/000476034.","journal-title":"Mol Neuropsychiatry"},{"issue":"4","key":"9728_CR54","first-page":"630","volume":"30","author":"T Mizui","year":"2005","unstructured":"Mizui T, Takahashi H, Sekino Y, Shirao T. Overexpression of drebrin A in immature neurons induces the accumulation of F-actin and PSD-95 into dendritic filopodia, and the formation of large abnormal protrusions. Mol Cell Neurosci. 2005;30(4):630\u20138.","journal-title":"Mol Cell Neurosci"},{"issue":"3","key":"9728_CR55","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.cell.2010.09.038","volume":"143","author":"SS Margolis","year":"2010","unstructured":"Margolis SS, Salogiannis J, Lipton DM, et al. EphB-mediated degradation of the RhoA GEF Ephexin5 relieves a developmental brake on excitatory synapse formation. Cell. 2010;143(3):442\u201355. https:\/\/doi.org\/10.1016\/j.cell.2010.09.038.","journal-title":"Cell"},{"issue":"2","key":"9728_CR56","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1523\/JNEUROSCI.1511-17.2017","volume":"38","author":"N Khatri","year":"2018","unstructured":"Khatri N, Gilbert JP, Huo Y, et al. The autism protein Ube3A\/E6AP remodels neuronal dendritic arborization via caspase-dependent microtubule destabilization. J Neurosci. 2018;38(2):363\u201378. https:\/\/doi.org\/10.1523\/JNEUROSCI.1511-17.2017.","journal-title":"J Neurosci"},{"issue":"4","key":"9728_CR57","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.stemcr.2023.02.002","volume":"18","author":"M Elamin","year":"2023","unstructured":"Elamin M, Dumarchey A, Stoddard C, et al. The role of UBE3A in the autism and epilepsy-related Dup15q syndrome using patient-derived, CRISPR-corrected neurons. Stem Cell Reports. 2023;18(4):884\u201398. https:\/\/doi.org\/10.1016\/j.stemcr.2023.02.002.","journal-title":"Stem Cell Reports"},{"issue":"1","key":"9728_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19336918.2024.2316576","volume":"18","author":"Y Wu","year":"2024","unstructured":"Wu Y, Zhao Y, Guan Z, Esmaeili S, Xiao Z, Kuriakose D. JNK3 inhibitors as promising pharmaceuticals with neuroprotective properties. Cell Adh Migr. 2024;18(1):1\u201311. https:\/\/doi.org\/10.1080\/19336918.2024.2316576.","journal-title":"Cell Adh Migr"}],"container-title":["Journal of Neurodevelopmental Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s11689-026-09728-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11689-026-09728-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11689-026-09728-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T07:13:31Z","timestamp":1790579611000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s11689-026-09728-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9728"],"URL":"https:\/\/doi.org\/10.1186\/s11689-026-09728-7","relation":{},"ISSN":["1866-1955"],"issn-type":[{"value":"1866-1955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,28]]},"assertion":[{"value":"10 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board (or Ethics Committee) of Istituto Auxologico Italiano, IRCCS (protocol code 2019_09_24_03).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the parents of the AS children and controls signed informed consent forms.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"56"}}